Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond-Reference-Cited by-同舟云学术

Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond

Published:2021-06 Issue:6 Volume:111 Page:1013-1017
ISSN:0090-0036
Container-title:American Journal of Public Health
language:en
Short-container-title:Am J Public Health

Author:

Barnett Brian S.¹,Wakeman Sarah E.¹,Davis Corey S.¹,Favaro Jamie¹,Rich Josiah D.¹

Affiliation:

1. Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Massachusetts General Hospital, and the Department of Medicine, Harvard Medical School, Boston. Corey S. Davis is with The Network for Public Health Law, Los Angeles, CA. Jamie Favaro is with NEXT Distro, New York, NY. Josiah D. Rich is with the Departments of Medicine and...

Publisher

American Public Health Association

Subject

Public Health, Environmental and Occupational Health

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains;Journal of the American Pharmacists Association;2024-01

2. Disruptions to naloxone training among lay and occupational responders in Maryland during the emergence of COVID-19: Early impacts, recovery, and lessons learned;Drug and Alcohol Dependence Reports;2023-09

3. Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA;Harm Reduction Journal;2023-01-07

4. Implementing syringe services programs within the Veterans Health Administration: facility experiences and next steps;Journal of the American Pharmacists Association;2023-01

5. Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population;Drug and Alcohol Dependence;2022-12